Home > Quotes > PFE

Pfizer, Inc. Stock Quote & Summary Data

Get PFE Alerts
*Delayed - data as of Dec. 17, 2014 14:50 ET  -  Find a broker to begin trading PFE now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    PFE Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
1 Year Target: 34
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 24,052,690
Previous Close: $ 30.67
52 Week High /Low: $ 33.1154 / $ 27.51
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 195,572,400,636
P/E Ratio: 19.16
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 13.57
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 1.62
Annualized dividend $ 1.04
Ex Dividend Date Nov. 5, 2014
Dividend Payment Date Dec. 2, 2014
Current Yield 3.39 %
Beta 0

Intraday Chart

ETFs with PFE as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
8.59% iShares U.S. Pharmaceutical ETF (IHE) +14.06  (10.58%)
8.07% Select Sector SPDR Fund - Health Care (XLV) +5.53  (8.94%)
7.57% iShares Dow Jones U.S. Health Care Index Fund (IYH) +11.88  (9.15%)
7.3% Merrill Lynch Pharmaceutical HOLDRS (PPH) +1.74  (2.82%)
7.22% First Trust Morningstar Dividend Leaders Index Fund (FDL) -0.78  (-3.25%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Pfizer Inc. is a research-based, global biopharmaceutical company. We apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. We work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Our revenues are derived from the sale of our products, and, to a much lesser extent, from alliance agreements, under which we co-promote products discovered by other companies (Alliance revenues).  ... More ...  

News for PFE

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?